Who Owns Dare Bioscience Stock?
NASDAQ: DAREHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
After hours: 0.7723 -0.14%
Ownership breakdown
- Held by institutions
- 13.37%
- Held by insiders
- 12.08%
- Institutional holders
- 32
- Institutions 13.4%
- Insiders 12.1%
- Public and other 74.6%
Who owns Dare Bioscience stock?
Institutional investors own about 13.4% of Dare Bioscience's shares, spread across 32 institutions that file 13F reports. That level of institutional ownership is relatively low, leaving more of the stock with retail investors and insiders. Insiders, including executives, directors and large founding shareholders, hold 12.08% of DARE.
The largest institutional holders are Vanguard Capital Management LLC (3.26%), Geode Capital Management, LLC (0.71%) and US BANCORP \DE\ (0.61%). Together, the top 10 institutions control 6.2% of shares outstanding. In their latest filings, 9 of the top 10 institutions increased their DARE positions and 1 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of DARE
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Vanguard Capital Management LLC | 640.88K | 3.26% | +38.6% |
| Geode Capital Management, LLC | 140.09K | 0.71% | -21.2% |
| US BANCORP \DE\ | 120.92K | 0.61% | +32.3% |
| Vanguard Fiduciary Trust Co | 91.27K | 0.46% | +38.4% |
| Blackrock Inc. | 64.25K | 0.33% | +278.6% |
| State Street Corporation | 47.41K | 0.24% | +101.6% |
| Jane Street Group, LLC | 36.09K | 0.18% | +100.0% |
| Northern Trust Corporation | 34.21K | 0.17% | +121.7% |
| HRT Financial LP | 22.43K | 0.11% | +100.0% |
| Virtu Financial LLC | 15.80K | 0.08% | +100.0% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of DARE
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 471.49K | 2.40% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 161.38K | 0.82% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 77.79K | 0.40% |
| iShares Trust-iShares Micro-Cap ETF | 44.99K | 0.23% |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 23.42K | 0.12% |
| Fidelity Concord Street Trust-Fidelity Total Market Index Fund | 15.33K | 0.08% |
| TR PRICE-Price (T.Rowe) U.S. Equities Trust | 13.32K | 0.07% |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 12.65K | 0.06% |
| VANGUARD VALLEY FORGE FUNDS-Vanguard Balanced Index Fund | 8.01K | 0.04% |
| EQ Advisors Trust-1290 VT Micro Cap Portfolio | 2.98K | 0.02% |
Frequently asked questions
Who is the largest shareholder of Dare Bioscience?
Vanguard Capital Management LLC is the largest institutional shareholder of DARE, owning 3.26% of shares outstanding (640.88K shares) as of its latest 13F filing.
What percentage of Dare Bioscience is owned by institutions?
Institutions own about 13.4% of DARE shares and 15.2% of the public float.
How much of Dare Bioscience do insiders own?
Insiders, such as officers and directors, own about 12.08% of DARE shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.